Zobrazeno 1 - 10
of 117
pro vyhledávání: '"Jasmina I Ivanova"'
Autor:
A. Simon Pickard, Lynn Huynh, Jasmina I. Ivanova, Todor Totev, Sophia Graham, Axel C. Mühlbacher, Anuja Roy, Mei Sheng Duh
Publikováno v:
Journal of Patient-Reported Outcomes, Vol 2, Iss 1, Pp 1-11 (2018)
Abstract Background Aplastic anemia is a rare, serious blood disorder due to bone marrow failure to produce blood cells. Transfusions are used to reduce risk of bleeding, infection and relieve anemia symptoms. In severe patients, transfusions may be
Externí odkaz:
https://doaj.org/article/9b416f81f8a943a18d5f6236c09a28fb
Autor:
MeganS Farris, Keith D. Wilner, Malaika Pastel, Devon J. Boyne, Kelly A Larkin-Kaiser, Jasmina I Ivanova, Tayler Scory, Joseph C. Cappelleri
Publikováno v:
Future Oncology. 16:3107-3116
Aim: To update overall survival (OS) results from a previous network meta analysis comparing the relative clinical efficacy of epidermal growth factor receptor-targeted tyrosine kinase inhibitors ( EGFR TKIs) for EGFR mutation positive ( EGFR+) advan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::880fbc91daacbf8b97bd2dc527f90a64
https://doi.org/10.2217/fon-2020-0541
https://doi.org/10.2217/fon-2020-0541
Autor:
Magaly Perez-Nieves, Beverly Reed, Irene Hadjiyianni, Samaneh Kalirai, Lawrence Fisher, Michael Grabner, Judith J. Stephenson, Roy Daniel Pollom, Caroline Geremakis, Jasmina I. Ivanova
Publikováno v:
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 13:1023-1033
Objective A survey of US adults with type 2 diabetes mellitus was conducted to better understand patients' insulin initiation experiences and treatment persistence behaviors. Research design and methods Participants were recruited from consumer panel
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::20f233dd0c13060a0eef48876363ab0b
https://doi.org/10.2147/dmso.s237948
https://doi.org/10.2147/dmso.s237948
Autor:
Todor Totev, Jasmina I. Ivanova, Mei Sheng Duh, Joseph H. Antin, Régis Peffault de Latour, Mehmet Bilginsoy, Lynn Huynh, Anuja Roy
Publikováno v:
Annals of Hematology. 99:743-752
This study assessed treatment patterns and healthcare resource utilization (HRU) of patients with severe aplastic anemia (SAA) with insufficient response to immunosuppressive therapy (IST). A retrospective chart review was conducted at Dana-Farber Ca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::007d6f0f6fc0b09c079621c3555d5a79
https://doi.org/10.1007/s00277-019-03809-5
https://doi.org/10.1007/s00277-019-03809-5
Publikováno v:
Journal of Clinical Oncology. 40:406-406
406 Background: Multiple life-prolonging therapies have been approved for mCRPC, for example novel hormonal therapies (NHT; abiraterone [abi], enzalutamide [enza]), docetaxel (doc), cabazitaxel, sipuleucel-T, and radium-223. This study describes real
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a24e1b8f016cd7c5eb42af66e51345fa
https://doi.org/10.1200/jco.2022.40.28_suppl.406
https://doi.org/10.1200/jco.2022.40.28_suppl.406
Publikováno v:
Journal of Clinical Oncology. 40:10-10
10 Background: Studies have reported healthcare costs before and after mCRPC diagnosis in commercially insured populations, but no information is available about costs with progression through lines of therapy after mCRPC diagnosis. This study descri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::296ce71f46460447cecb0399e5232d8d
https://doi.org/10.1200/jco.2022.40.28_suppl.010
https://doi.org/10.1200/jco.2022.40.28_suppl.010
Autor:
Thomas J Ferro, James M Pitcavage, Wendy Y. Cheng, Rinat Ariely, Agnes S. Sundaresan, Ruchir Parikh, Jasmina I. Ivanova, Luke Schmerold
Publikováno v:
Allergy and Asthma Proceedings. 40:21-31
Background: Asynchrony, or lack of coordination between inhalation and actuation when using a pressurized metered-dose inhaler (MDI), could theoretically impact the delivery of inhaled medications and treatment efficacy. Objective: To assess the real
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91f517f729730af5ca24908d78d358c0
https://doi.org/10.2500/aap.2019.40.4192
https://doi.org/10.2500/aap.2019.40.4192
Publikováno v:
Journal of medical economics. 24(1)
Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) over chemotherapy inA partitioned survival model was developed with three health states: progression-free, post-progression, and death. Progr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::0939aaa84aafb93648dcf985f875ed04
https://pubmed.ncbi.nlm.nih.gov/33754924
https://pubmed.ncbi.nlm.nih.gov/33754924
PurposeOsteoarthritis (OA) is a frequently occurring, chronic condition; however, few studies describe the clinical characteristics of individuals with OA and the treatments they use to manage their symptoms. We conducted a study to characterize the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e9e0e7c7742e0ff8939fdc203e8d7e18
https://escholarship.org/uc/item/7d72p0s7
https://escholarship.org/uc/item/7d72p0s7
Although the benefit of first-line epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors (TKIs) over chemotherapy in EGFR mutation-positive (EGFRm) non-small-cell lung cancer (NSCLC) has been demonstrated in clinical trials, the optimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::83da86bedfd371ac4abfe98d67a23c98